The 79th Annual Meeting of the Japanese Cancer Association

English

Secretariat

Department of Molecular Pathology,
Institute of Biomedical & Health Sciences Hiroshima University
1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima, Japan 734-8553

Congress Secretariat

Japan Convention Services, Inc. Kansai Branch
Keihanshin Yodoyabashi Bldg. 2F 4-4-7, Imabashi, Chuo-ku, Osaka 541-0042 Japan
E-mail: jca2020[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . )

Category

Abstract Submission

1. Chemical carcinogenesis and radiation carcinogenesis

1-1Activation and metabolism of carcinogens
1-2Detection and assessment of carcinogens
1-3DNA damage
1-4Process of carcinogenesis
1-5Nitric oxide/reactive oxygen
1-6Genotoxins and nongenotoxins
1-7Experimental cell culture systems
1-8Radiation and electromagnetic wave carcinogenesis
1-9Others

2. Experimental animal models and genetically-engineered animals

2-1Gene-manipulated animal models
2-2Animal model for carcinogenesis
2-3Patient-derived experimental model
2-4Others

3. Virus, infection, inflammation and cancer

3-1EBV
3-2HPV
3-3HBV
3-4HCV
3-5HTLV-1
3-6HHV-8
3-7H.pylori
3-8Other viruses/bacteria
3-9Intestinal bacteria/microbiome
3-10Inflammation and cancer

4. Oncogenes and tumor-suppressor genes

4-1ras family genes
4-2p53-related genes
4-3Rb/p16-related genes
4-4Wnt signaling-related genes
4-5Chromosomal translocation-related genes
4-6Other oncogenes/tumor-suppressor genes
4-7Novel oncogenes/tumor-suppressor genes

5. Signal transduction and gene expression

5-1Proliferation/differentiation
5-2Signal transduction
5-3Transcriptional regulation
5-4Translational regulation
5-5RNA engineering
5-6ncRNA・microRNA
5-7Others

6. DNA replication/cell cycle/genomic instability

6-1Cell cycle/checkpoint
6-2DNA replication
6-3DNA repair
6-4Genetic instability

7. Cancer genome/genetics

7-1Genomic analysis
7-2Genomic medicine
7-3NGS
7-4Genome editing
7-5Homozygous deletion/positional cloning
7-6Chromosomal translocation/gene rearrangement
7-7Gene amplification
7-8Familial tumor and target genes
7-9Carcinogenic sensitivity-related genes (SNPs)
7-10Others

8. Cell death/immortalization

8-1Cell death
8-2Telomere/senescence/immnortalization
8-3Others

9. Epigenetics

9-1DNA methylation
9-2Histone modification
9-3Chromatin structure
9-4Others

10. Invasion and metastasis

10-1Cell adhesion/invasion
10-2Extracellular matrices and proteases
10-3Metastasis-associated genes
10-4Angiogenesis
10-5Diagnosis of metastasis
10-6Metastasis inhibition
10-7Metastasis models
10-8Others

11. Characteristics of cancer cells

11-1Cancer stem cells
11-2Cell differentiation
11-3Cell-to-cell interaction/adhesion molecules
11-4Cell lines
11-5Organoid
11-6Carbohydrate chains and glycosyltransferases
11-7Extracellular vesicles/Exosome
11-8Metabolism / Metabolome
11-9Others

12. Cancer immunity

12-1Innate immunity
12-2Dendritic cells/antigen-presenting cells
12-3Tumor antigens
12-4Antitumor effector cells and their induction
12-5Immune checkpoint inhibitors
12-6Vaccination therapy
12-7Antibody therapy
12-8Other immunotherapies
12-9Others

13. Growth factors/cytokines/hormones

13-1Growth- and differentiation-regulating factors
13-2Growth factor receptors
13-3Hormones
13-4Cytokines
13-5TGF-b/Smad

14. Cancer basic, diagnosis and treatment

14-1Gastric cancer
14-2Esophageal cancer
14-3Colorectal cancer
14-4GIST
14-5Hepatocellular cancer
14-6Carcinoma of the biliary tract
14-7Pancreatic cancer
14-8Lung cancer
14-9Breast cancer
14-10Uterine cancer
14-11Ovarian cancer
14-12hematopoietic malignancy
14-13Renal cell cancer
14-14Bladder cancer
14-15Prostatic cancer
14-16Testicular cancer
14-17Brain tumor
14-18Primary bone tumor
14-19Soft tissue sarcoma
14-20Head and neck cancer
14-21Endocrine cancer
14-22Skin cancer
14-23Childhood cancer/AYA
14-24Other organs

15. Diagnosis

15-1Pathological diagnosis
15-2Diagnostic imaging
15-3Diagnosis by tumor markers and biomarkers
15-4Genomic diagnostics
15-5Diagnosis by expression analysis (mRNA, protein)
15-6Novel diagnostic technology
15-7Liquid biopsy
15-8Artificial intelligence based diagnostics
15-9Others

16. Molecular-targeting therapy

16-1Signal transduction inhibitors/kinase inhibitors
16-2Angiogenesis inhibitors/antimetastatic drugs
16-3Cell cycle inhibitors (CDK inhibitors etc.)
16-4Transcription modulators (histone deacetylase inhibitors etc.)
16-5Others

17. Chemotherapy and endocrine therapy

17-1Natural anticancer compounds
17-2Synthetic anticancer compounds
17-3DNA-damaging drug (Platinum compounds/Topoisomerase inhibitors etc.)
17-4Antimetabolites
17-5Antimicrotubular drugs (taxane/alkaloids etc.)
17-6Anticancer drug resistance
17-7Anticancer drug and cell death
17-8Endocrine therapy
17-9Differentiation-inducing therapy
17-10Drug delivery system
17-11Combinational therapy/adjuvant therapy
17-12Others

18. Evaluation and prediction of pharmacological effects

18-1Drug sensitivity/drug resistance-relating factors/gene expression analysis
18-2Pharmacokinetics/pharmacodynamics (PK/PD)
18-3Pharmacogenomics/toxicogenomics (SNPs, transcriptome, proteome)
18-4Sensitivity test
18-5Clinical trial
18-6Biobank

19. Radiation therapy

19-1Radiation and particle ray therapy
19-2Radiation hazard/protection
19-3Radiosensitivity
19-4Efficacy enhancement
19-5Hyperthermia
19-6Others

20. Cell therapy and regeneration medicine

20-1Stem cells
20-2Regenerative medicine
20-3Cell therapy of allograft
20-4Others

21. Gene therapy

21-1Generation and modification of vectors
21-2Immunogenetic therapy
21-3Oncogene/tumor-suppressor gene therapy
21-4Suicide gene therapy
21-5Nucleic acid therapeutics (including DDS)
21-6Others

22. Medical care of progressive cancer

22-1Psychooncology
22-2Palliative treatment and care
22-3Others

23. Cancer prevention/chemoprevention

23-1Mechanism of cacinogenesis inhibition
23-2Synthetic compounds
23-3Natural products
23-4Dietary/alimentary factors
23-5Others

24. Epidemiology

24-1Environmental factors (life habits etc.)/infectious exposure
24-2Cancer prone syndromes/molecular epidemiology
24-3Cohort study
24-4Descriptive epidemiology/cancer registration
24-5Cancer screening
24-6Others

25. Information/informatics

25-1Bioinfomatics
25-2Management and analysis of cancer patients' data
25-3Others

26. Cancer and society

26-1Informed consent
26-2Bioethics
26-3Social movement against cancer
26-4Smoking and drinking alcohol
26-5Others

page top